Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group studyAlan F. List, Frederick R. Appelbaum, Cheryl L. Willman et al.|Blood|2001Cited by 419